Baxter Fined $4.4M For Bundling IV Fluid Contracts

Law360, New York (August 31, 2010, 3:50 PM EDT) -- An Australian judge has fined pharmaceutical company Baxter Healthcare Pty. Ltd. AU$4.9 million ($4.4 million) for allegedly entering into long-term bundled contracts to provide intravenous fluids to public hospitals in violation of antitrust law.

Justice John Ronald Mansfield of the Federal Court of Australia issued the penalty Thursday, after the court's 2008 decision finding Baxter in breach of the Trade Practices Act of 1974.

The case began in 2002, when the Australian Competition and Consumer Commission accused Baxter of misusing its market power when it entered...
To view the full article, register now.